Trial · NCT00927186
Results by group252
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 252
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mineralizing Surface/Bone Surface (MS/BS) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | Teriparatide | 5.60 | Inter-Quartile Range 10.20 | percentage of surface | |
| Mineralizing Surface/Bone Surface (MS/BS) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | Zoledronic Acid | 0.16 | Inter-Quartile Range 2.62 | percentage of surface | |
| Mineralizing Surface/Bone Surface (MS/BS) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | Teriparatide | 3.00 | Inter-Quartile Range 1.49 to 4.58 | percentage of surface | |
| Mineralizing Surface/Bone Surface (MS/BS) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | Zoledronic Acid | 0.07 | Inter-Quartile Range 0.00 to 0.42 | percentage of surface | |
| Mineralizing Surface/Bone Surface(MS/BS) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | Teriparatide | 6 months (n=23, 29) | 18.64 | Inter-Quartile Range 9.25 to 21.96 | percentage of surface |
| Mineralizing Surface/Bone Surface(MS/BS) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | Zoledronic Acid | 6 months (n=23, 29) | 0.30 | Inter-Quartile Range 0.00 to 0.84 | percentage of surface |
| Mineralizing Surface/Bone Surface(MS/BS) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | Teriparatide | 24 months (n=9, 8) | 5.82 | Inter-Quartile Range 3.10 to 7.08 | percentage of surface |
| Mineralizing Surface/Bone Surface(MS/BS) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | Zoledronic Acid | 24 months (n=9, 8) | 0.00 | Inter-Quartile Range 0.00 to 0.91 | percentage of surface |
| Activation Frequency (Ac.f) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | Teriparatide | DL and NL (n=28, 28) | 0.37 | Inter-Quartile Range 0.17 to 0.82 | new cycles/year |
| Activation Frequency (Ac.f) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | Zoledronic Acid | DL and NL (n=28, 28) | 0.01 | Inter-Quartile Range 0.00 to 0.04 | new cycles/year |
| Activation Frequency (Ac.f) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | Teriparatide | DL, Imputed SL (ISL) and NL (n=28, 30) | 0.37 | Inter-Quartile Range 0.17 to 0.82 | new cycles/year |
| Activation Frequency (Ac.f) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | Zoledronic Acid | DL, Imputed SL (ISL) and NL (n=28, 30) | 0.01 | Inter-Quartile Range 0.00 to 0.03 | new cycles/year |
| Activation Frequency (Ac.f) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | Teriparatide | DL and NL (n=9, 6) | 0.19 | Inter-Quartile Range 0.10 to 0.20 | new cycles/year |
| Activation Frequency (Ac.f) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | Zoledronic Acid | DL and NL (n=9, 6) | 0.00 | Inter-Quartile Range 0.00 to 0.02 | new cycles/year |
| Activation Frequency (Ac.f) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | Teriparatide | DL, Imputed SL (ISL) and NL (n=10, 9) | 0.18 | Inter-Quartile Range 0.08 to 0.20 | new cycles/year |
| Activation Frequency (Ac.f) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | Zoledronic Acid | DL, Imputed SL (ISL) and NL (n=10, 9) | 0.00 | Inter-Quartile Range 0.00 to 0.02 | new cycles/year |
| Activation Frequency (Ac.f) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | Teriparatide | DL and NL at 6 Months (n=23, 20) | 0.83 | Inter-Quartile Range 0.49 to 1.09 | new cycles/year |
| Activation Frequency (Ac.f) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | Zoledronic Acid | DL and NL at 6 Months (n=23, 20) | 0.00 | Inter-Quartile Range 0.00 to 0.07 | new cycles/year |
| Activation Frequency (Ac.f) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | Teriparatide | DL, Imputed SL (ISL) and NL at 6 Months (n=23, 29) | 0.83 | Inter-Quartile Range 0.49 to 1.09 | new cycles/year |
| Activation Frequency (Ac.f) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | Zoledronic Acid | DL, Imputed SL (ISL) and NL at 6 Months (n=23, 29) | 0.01 | Inter-Quartile Range 0.00 to 0.04 | new cycles/year |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00927186/results